Experts worry over TB treatment resistance, transmission

Feb 131 min read

A new study revealed that resistance is developing to the 6-month BPaLM regimen

recommended by the WHO. The study investigated around 90,000 strains of M.

tuberculosis from around the world and found that 28% showed resistance to both older

and new treatment options, including the BPaLM regimen. Additionally, resistant strain

transmission is being observed between patients. Read more here.

Recent Posts

Preliminary findings from the phase 1B PanACEA trial shows promising results for a new antibiotic, BTZ-043. The aim is to create an...

A new initiative in Nigeria aims to provide state health insurance to any patient with drug resistant TB in the country. Implementation...

The results of the TB-CHAMP trial were recently published. They showed that prophylactic levofloxacin can significantly reduce the risk...